Ono Pharmaceutical Co Ltd
TSE:4528
Ono Pharmaceutical Co Ltd
Revenue
Ono Pharmaceutical Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ono Pharmaceutical Co Ltd
TSE:4528
|
Revenue
¥498.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Revenue
¥4.2T
|
CAGR 3-Years
9%
|
CAGR 5-Years
19%
|
CAGR 10-Years
10%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Revenue
¥1.5T
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Revenue
¥2T
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Revenue
¥1.1T
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
Astellas Pharma Inc
TSE:4503
|
Revenue
¥1.9T
|
CAGR 3-Years
15%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
See Also
What is Ono Pharmaceutical Co Ltd's Revenue?
Revenue
498.1B
JPY
Based on the financial report for Dec 31, 2023, Ono Pharmaceutical Co Ltd's Revenue amounts to 498.1B JPY.
What is Ono Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
13%
Over the last year, the Revenue growth was 16%. The average annual Revenue growth rates for Ono Pharmaceutical Co Ltd have been 18% over the past three years , 12% over the past five years , and 13% over the past ten years .